Pulsenmore Secures $1 Million Grant for AI-Driven Ultrasound Development

The initiative, co-sponsored by the Israel Innovation Authority and the Ministry of Health, creates a specialized regulatory environment for testing medical technologies. By collaborating with Beilinson Hospital, part of the Clalit Health Services network, Pulsenmore intends to transform its existing database into an intelligent software layer. Currently, every scan performed via the company's smartphone-connected device requires manual physician review. The new AI applications aim to automatically identify key parameters, allowing specialists to focus on high-priority cases and address the global shortage of skilled diagnostic professionals.

Dr. Elazar Sonnenschein, CEO of Pulsenmore, noted that the project represents a shift in the platform’s evolution, moving from simple connectivity to active clinical support. By integrating automated findings into the diagnostic process, the company expects to reduce review times and expand the capacity of healthcare providers without sacrificing quality. The program provides a clear pathway for integrating these tools into both the Israeli healthcare system and international markets, leveraging real-world data collected since the platform's launch.